BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32462397)

  • 21. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
    Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
    Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.
    Meyer PF; Pichet Binette A; Gonneaud J; Breitner JCS; Villeneuve S
    JAMA Neurol; 2020 Apr; 77(4):508-516. PubMed ID: 31961372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head-to-head comparison of tau positron emission tomography tracers [
    Smith R; Schöll M; Leuzy A; Jögi J; Ohlsson T; Strandberg O; Hansson O
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):342-354. PubMed ID: 31612245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.
    Albrecht D; Isenberg AL; Stradford J; Monreal T; Sagare A; Pachicano M; Sweeney M; Toga A; Zlokovic B; Chui H; Joe E; Schneider L; Conti P; Jann K; Pa J
    J Neurosci; 2020 Oct; 40(44):8573-8586. PubMed ID: 33046556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study.
    Parbo P; Ismail R; Sommerauer M; Stokholm MG; Hansen AK; Hansen KV; Amidi A; Schaldemose JL; Gottrup H; Brændgaard H; Eskildsen SF; Borghammer P; Hinz R; Aanerud J; Brooks DJ
    Neurobiol Dis; 2018 Sep; 117():211-216. PubMed ID: 29902557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.
    Colato E; Chiotis K; Ferreira D; Mazrina MS; Lemoine L; Mohanty R; Westman E; Nordberg A; Rodriguez-Vieitez E;
    J Alzheimers Dis; 2021; 84(1):103-117. PubMed ID: 34511502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease.
    Phillips JS; Das SR; McMillan CT; Irwin DJ; Roll EE; Da Re F; Nasrallah IM; Wolk DA; Grossman M
    Hum Brain Mapp; 2018 Feb; 39(2):691-708. PubMed ID: 29105977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatially constrained kinetic modeling with dual reference tissues improves
    Zhou Y; Flores S; Mansor S; Hornbeck RC; Tu Z; Perlmutter JS; Ances B; Morris JC; Gropler RJ; Benzinger TLS
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3172-3186. PubMed ID: 33599811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease.
    Terada T; Yokokura M; Obi T; Bunai T; Yoshikawa E; Ando I; Shimada H; Suhara T; Higuchi M; Ouchi Y
    J Neurol; 2019 Sep; 266(9):2186-2196. PubMed ID: 31139959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-sectional associations between [
    Teng E; Ward M; Manser PT; Sanabria-Bohorquez S; Ray RD; Wildsmith KR; Baker S; Kerchner GA; Weimer RM
    Neurobiol Aging; 2019 Sep; 81():138-145. PubMed ID: 31280117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD.
    Wang X; Sundermann EE; Buckley RF; Banks SJ;
    Alzheimers Dement; 2024 Jan; 20(1):25-33. PubMed ID: 37641484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compensating for choroid plexus based off-target signal in the hippocampus using
    Pawlik D; Leuzy A; Strandberg O; Smith R
    Neuroimage; 2020 Nov; 221():117193. PubMed ID: 32711062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.
    Cho H; Choi JY; Lee HS; Lee JH; Ryu YH; Lee MS; Jack CR; Lyoo CH
    J Nucl Med; 2019 Nov; 60(11):1611-1621. PubMed ID: 30926651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Test-retest repeatability of [
    Timmers T; Ossenkoppele R; Visser D; Tuncel H; Wolters EE; Verfaillie SC; van der Flier WM; Boellaard R; Golla SS; van Berckel BN
    J Cereb Blood Flow Metab; 2020 Dec; 40(12):2464-2474. PubMed ID: 31575335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Head-to-head comparison of relative cerebral blood flow derived from dynamic [
    Tuncel H; Visser D; Timmers T; Wolters EE; Ossenkoppele R; van der Flier WM; van Berckel BNM; Boellaard R; Golla SSV
    EJNMMI Res; 2023 Oct; 13(1):93. PubMed ID: 37889456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β-negative cognitively normal individuals.
    Groot C; Doré V; Robertson J; Burnham SC; Savage G; Ossenkoppele R; Rowe CC; Villemagne VL
    Neurobiol Aging; 2021 Jan; 97():41-48. PubMed ID: 33130455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vivo Assessment of Tau Deposition in Alzheimer Disease and Assessing Its Relationship to Regional Brain Glucose Metabolism and Cognition.
    Baghel V; Tripathi M; Parida G; Gupta R; Yadav S; Kumar P; Dey AB; Damle NA; Kumar R; Bal C
    Clin Nucl Med; 2019 Nov; 44(11):e597-e601. PubMed ID: 31584490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.